The role of the 3D environment in hypoxia-induced drug and apoptosis resistance

Anticancer Research

Volumn 31, Issue 10, 2011, Pages 3237-3245

  Kim, Jun W ^a   Ho, Won Jin ^a   Wu, Benjamin M ^a  

^a Department of Civil and Environmental Engineering   (United States)

Author keywords

Anticancer drug and apoptosis; Anticancer drug resistance; Cell to cell interaction adhesion molecules; Characteristics of cancer cells; Chemotherapy; Drug sensitivity drug resistance relating factors gene expression analysis; Evaluation and prediction of pharmacological effects; Screening systems

Indexed keywords

CASPASE 3; DOXORUBICIN; FIBROBLAST GROWTH FACTOR 2; MOLECULAR SCAFFOLD; PROTEIN BCL 2; RESVERATROL; SURVIVIN; VASCULOTROPIN;

APOPTOSIS; ARTICLE; ASTROCYTOMA CELL; DRUG RESISTANCE; ENZYME ACTIVITY; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA ASSOCIATED APOPTOSIS; IMAGE ANALYSIS; IN VITRO STUDY; NANOFABRICATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; SPHEROID CELL; THREE DIMENSIONAL ENVIRONMENT; TUMOR MICROENVIRONMENT;

APOPTOSIS; CELL HYPOXIA; CELL LINE, TUMOR; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INHIBITOR OF APOPTOSIS PROTEINS; INHIBITORY CONCENTRATION 50; PROTO-ONCOGENE PROTEINS C-BCL-2; SPHEROIDS, CELLULAR; TISSUE SCAFFOLDS; TUMOR MICROENVIRONMENT; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80054716821     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Khaitan D, Chandna S, Arya MB and Dwarakanath BS: Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy. J Transi Med 4: 12-25, 2006.
2. Chen YQ, Zhao CL and Li W: Effect of hypoxia-inducible factor-1 alpha on transcription of survivin in non-small cell lung cancer. J Exp Clin Cancer Res 28: 29-37, 2009.
3. Wang JH, Wu QD, Bouchier-Hayes D and Redmond HP: Hypoxia up-regulates BCL-2 expression and suppresses interferon-gamma induced antiangiogenic activity in human tumor-derived endothelial cells. Cancer 94(10): 2745-2755, 2002. (Pubitemid 34478093)
4. Fechner G, Müller G, Schmidt D, Garbe S, Hauser S, Vaupel P and Müller SC: Evaluation of hypoxia-mediated growth factors in a novel bladder cancer animal model. Anticancer Res 27: 4225-4232, 2007.
5. Hengartner MO: The biochemistry of apoptosis. Nature 407(6805): 770-776, 2000.
6. Yang TM, Barbone D, Fennell DA and Broaddus VC: BCL-2 family proteins contribute to apoptotic resistance in lung cancer multicellular spheroids. Am J Respir Cell Mol Biol 41(1): 14-23, 2009.
7. Fornaro M, Plescia J, Chheang S, Tallini G, Zhu YM, King M, Altieri DC and Languino LR: Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway. J Biol Chem 278(50): 50402-50411, 2003. (Pubitemid 37548884)
8. Doillon CJ, Gagnon E, Paradis R and Koutsilieris M: Three-dimensional culture system as a model for studying cancer cell invasion capacity and anticancer drug sensitivity. Anticancer Res 24: 2169-2178, 2004.
9. Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge JS, Polverini PJ and Mooney DJ: Engineering tumors with 3D scaffolds. Nat Methods 4(10): 855-860, 2007. (Pubitemid 350055585)
10. Horning JL, Sahoo SK, Vijayaraghavalu S, Dimitrijevic S, Vasir JK, Jain TK, Panda AK and Labhasetwar V: 3-D tumor model for in vitro evaluation of anticancer drugs. Mol Pharm 5(5): 49-862, 2008.
11. Ho WJ, Pham EA, Kim JW, Ng CW, Kim JH, Kamei DT and Wu BM: Incorporation of multicellular spheroids into 3-D polymeric scaffolds provides an improved tumor model for screening anticancer drugs. Cancer Sci 101(12): 2637-2643, 2010.
12. Lee M, Wu BM, Stelzner M, Reichardt HM and Dunn JC: Intestinal smooth muscle cell maintenance by basic fibroblast growth factor. Tissue Eng Part A 14(8): 1395-1402, 2008.
13. Ivascu A and Kubbies M. Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis. J Biomol Screen 11(8): 922-932, 2006. (Pubitemid 44847146)
14. Harisi R, Dudas J, Timar F, Pogancy G, Paku S, Timar J, Kovalszky I, Szendroi M and Jeney A: Antiproliferative and antimigratory effects of doxorubicin in human osteosarcoma cells exposed to extracellular matrix. Anticancer Res 25: 805-814, 2005.
15. Jiang H, Zhang L, Kuo J, Kuo K, Gautam SC, Groc L, Rodriguez AI, Koubi D, Hunter TJ, Corcoran GB, Seidman MD and Levine RA: Resveratrol-induced apoptotic death in human U251 glioma cells. Mol Cancer Ther 4(4): 554-561, 2005. (Pubitemid 40601836)
16. Bache M, Holzapfel D, Kappler M, Holzhausen HJ, Taubert H, Dunst J and Hänsgen G: Survivin protein expression and hypoxia in advanced cervical carcinoma of patients treated by radiotherapy. Gynecol Oncol 104(1): 139-144, 2007. (Pubitemid 46054113)
17. Kantak SS and Kramer RH: E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J Biol Chem 273(27): 16953-16961, 1998. (Pubitemid 28311727)
18. Tran NL, Adams DG, Vaillancourt RR and Heimark RL: Signal transduction from N-cadherin increases BCL-2. Regulation of the phosphatidylinositol 3-kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization. J Biol Chem 277(36): 32905-32914, 2002. (Pubitemid 34984804)
19. 2+/ calmodulin-dependent protein kinase IV. J Cell Biochem 95(6): 1214-1223, 2005.
20. Kardosh A, Soriano N, Pyrko P, Liu YT, Jabbour M, Hofman FM and Schönthal AH: Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib. J Biomed Sci 14(5): 647-662, 2007. (Pubitemid 47414767)
21. Alavi A, Hood JD, Frausto R, Stupack DG and Cheresh DA: Role of Raf in vascular protection from distinct apoptotic stimuli. Science 301(5629): 94-96, 2003. (Pubitemid 36801568)
22. Bos R, van Diest PJ, van der Groep P, Shvarts A, Greijer AE and van der Wall E: Expression of hypoxia-inducible factor-1 alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related. Breast Cancer Res 6(4): R450-459, 2004.
23. Wang HG, Rapp UR and Reed JC: BCL-2 targets the protein kinase Raf-1 to mitochondria. Cell 87(4): 629-638, 1996. (Pubitemid 26386937)
24. Erhardt P, Schremser EJ and Cooper GM: B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway. Mol Cell Biol 19(8): 5308-5315, 1999. (Pubitemid 29339890)
25. Allan LA, Morrice N, Brady S, Magee G, Pathak S and Clarke PR: Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat Cell Biol 5(7): 647-654, 2003. (Pubitemid 36818087)
26. Dohi T, Beltrami E, Wall NR, Plescia J and Altieri DC: Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J Clin Invest 114(8): 1117-1127, 2004. (Pubitemid 39578701)
27. Brown DA, MacLellan WR, Laks H, Dunn JC, Wu BM and Beygui RE: Analysis of oxygen transport in a diffusion-limited model of engineered heart tissue. Biotechnol Bioeng 97(4): 962-975, 2007. (Pubitemid 47051064)
28. Dunn JC, Chan WY, Cristini V, Kim JS, Lowengrub J, Singh S and Wu BM: Analysis of cell growth in three-dimensional scaffolds. Tissue Eng 12(4): 705-716, 2006. (Pubitemid 43726515)
29. Nishimura I, Garrell RL, Hedrick M, Iida K, Osher S and Wu B: Precursor tissue analogs as a tissue-engineering strategy. Tissue Eng 9(Suppl 1): S77-89, 2003. (Pubitemid 37046608)
30. Saitoh Y, Yaginuma Y and Ishikawa M: Analysis of BCL-2, Bax and Survivin genes in uterine cancer. Int J Oncol 15(1): 137-141, 1999.
31. Timmer A, Oosterhuis JW, Schraffordt Koops H, Sleijfer DT, Szabo BG and Timens W: The tumor microenvironment: possible role of integrins and the extracellular matrix in tumor biological behavior of intratubular germ cell neoplasia and testicular seminomas. Am J Pathol 144(5): 1035-1044, 1994. (Pubitemid 24160644)
32. Ciardiello F and Tortora G: Inhibition of BCL-2 as cancer therapy. Ann Oncol 13: 501-502, 2002. (Pubitemid 34461131)
33. Ryan BM, O'Donovan N and Duffy MJ: Survivin: a new target for anticancer therapy. Cancer Treat Rev 35(7): 553-562, 2009.
34. Dong Z, Venkatachalam MA, Wang J, Patel Y, Saikumar P, Semenza GL, Force T and Nishiyama J: Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. HIF-1 independent mechanisms. J Biol Chem 276(22): 18702-18709, 2001. (Pubitemid 37411184)